News | April 04, 2025
Lupin acquires UK-based Renascience Pharma for £12.3 million
The portfolio includes branded injectable cephalosporines for infectious diseases
The portfolio includes branded injectable cephalosporines for infectious diseases
Subscribe To Our Newsletter & Stay Updated